-
16
2018-11On Nov. 14th~16th, BravoVax was invited to attend the 2018 China -
14
2018-11In Oct., 2018, Dr. Zhuang Zaicheng, Chief Operation Officer of BravoVax Co., Ltd, was awarded the title “Enterprise Innovation Talent” of the 11th “3551 Optics Valley Talent Schema” by Wuhan East ··· -
25
2018-10On 19th October, 2018, BravoVax Co., Ltd. was officially approved by the Management Committee of Wuhan East Lake High-tech Development Zone as the "Gazelle Enterprises." BravoVax was awarded -
24
2018-08On 22th Aug. , BravoVax signed contract with College of Life -
02
2018-08On July 29th~31th, BravoVax was invited to attend the 2018 China -
04
2018-07On June 25th~27th, BravoVax was invited to attend the 2018 China Human &Veterinary Vaccine Industry Summit held at Hyatt Regency Tianjin East. The meeting highlighted on the policy and future tre -
17
2018-05BravoVax Co., Ltd (BravoVax) recently signed exclusive license agreement with National Institutes of Health (NIH), U.S. and obtained the exclusive product development, marketing rights and patent lice -
15
2018-03On March 8th, 2018, Dean Lixin. Ma from Academy of Life Sciences of Hubei University visited BravoVax and met its managing leadership in a relaxed atmosphere. In the meeting, CEO Dr. Wu of BravoVax ad -
06
2018-02On Jan. 29th, 2018, BravoVax has been awarded the title of “Enterprise Technology Center” by Hubei Provincial Development and Reform Commission. -
30
2018-01On January 30, 2018, BravoVax Co., Ltd was preliminarily assessed by the Credit Guarantee Committee, China Association for Small & Medium Commercial Enterprises, and approved by the Credit Rating -
19
2018-01BravoVax Co., Ltd (BravoVax) recently signed exclusive license agreement with one of the most prestigious universities in the U.S. and obtained the exclusive patent license, product development and ma -
17
2018-01On January 17, 2018, BravoVax Co., Ltd was awarded the title of “National Innovation Business Good Faith Demonstration Unit” by the Credit Guarantee Committee, China Association for Small & Medium -
06
2017-12In Dec. 2017, Dr. Yan Liming was awarded subsidies from Bureau of Personnel of Wuhan Municipality, which will be put in use of scientific research. -
06
2017-12On 30th December, 2017, BravoVax Co., Ltd. was officially approved by the Management Committee of Wuhan East Lake High-tech Development Zone as the "Gazelle Enterprises." BravoVax was awarde -
08
2017-09On September 7th, 2017, leaders from Rockwell Automation (China) visited BravoVax and had deep communication with leaderships and chief industrial engineer from BravoVax. After the brief meeting, the